Antimicrobial prophylaxis in women with recurrent urinary tract infections

International Journal of Antimicrobial Agents

Volumn 38, Issue SUPPL., 2011, Pages 36-41

  Lichtenberger, Paola ^a   Hooton, Thomas M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Antimicrobial prophylaxis; Prophylactic antimicrobials; Recurrent UTI; Suppressive treatment

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CEFACLOR; CEFADROXIL; CEFALEXIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; FOSFOMYCIN TROMETAMOL; LEVOFLOXACIN; MACROLIDE; METRONIDAZOLE; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; ORAL CONTRACEPTIVE AGENT; PEFLOXACIN; PENICILLIN DERIVATIVE; PLACEBO; PROBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SPERMICIDAL AGENT; SULFAMETHOXAZOLE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM; VACCINE;

ACHILLES TENDON RUPTURE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; CHEMOPROPHYLAXIS; CLOSTRIDIUM DIFFICILE INFECTION; COITUS; CRANBERRY; CYSTITIS; DOSAGE SCHEDULE COMPARISON; DRUG ANTAGONISM; DRUG CHOICE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HUMAN; NONHUMAN; PRIORITY JOURNAL; RECURRENT INFECTION; SELF CARE; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; THRUSH; URINARY TRACT INFECTION; VACCINATION; VAGINA CANDIDIASIS;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; FEMALE; HUMANS; RECURRENCE; URINARY TRACT INFECTIONS;

EID: 82655187162     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.09.005     Document Type: Article

References (60)

1. B. Foxman Recurring urinary tract infection: incidence and risk factors Am J Public Health 80 1990 331 333 (Pubitemid 20080925)
2. B. Foxman, B. Gillespie, J. Koopman, L. Zhang, K. Palin, and P. Tallman Risk factors for second urinary tract infection among college women Am J Epidemiol 151 2000 1194 1205 (Pubitemid 30451952)
3. R. Ikäheimo, A. Siitonen, T. Heiskanen, U. Kärkkäinen, P. Kuosmanen, and P. Lipponen Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women Clin Infect Dis 22 1996 91 99 (Pubitemid 26022018)
4. A. Pfau, T. Sacks, and D. Engelstein Recurrent urinary tract infections in premenopausal women: prophylaxis based on an understanding of the pathogenesis J Urol 129 1983 1153 1157 (Pubitemid 13060317)
5. K. Gupta, and W.E. Stamm Pathogenesis and management of recurrent urinary tract infections in women World J Urol 17 1999 415 420
6. J.E. Fowler Jr., and E.T. Pulaski Excretory urography, cystography, and cystoscopy in the evaluation of women with urinary-tract infection: a prospective study N Engl J Med 304 1981 462 465 (Pubitemid 11179003)
7. M.A. Mulvey, J.D. Schilling, J.J. Martinez, and S.J. Hultgren Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses Proc Natl Acad Sci USA 97 2000 8829 8835 (Pubitemid 30626633)
8. D.A. Rosen, T.M. Hooton, W.E. Stamm, P.A. Humphrey, and S.J. Hultgren Detection of intracellular bacterial communities in human urinary tract infection PLoS Med 4 2007 pe329
9. D. Scholes, T.M. Hooton, P.L. Roberts, A.E. Stapleton, K. Gupta, and W.E. Stamm Risk factors for recurrent urinary tract infection in young women J Infect Dis 182 2000 1177 1182
10. D. Scholes, T.R. Hawn, P.L. Roberts, S.S. Li, A.E. Stapleton, and L.P. Zhao Family history and risk of recurrent cystitis and pyelonephritis in women J Urol 184 2010 564 569
11. R. Raz, Y. Gennesin, J. Wasser, Z. Stoler, S. Rosenfeld, and E. Rottensterich Recurrent urinary tract infections in postmenopausal women Clin Infect Dis 30 2000 152 156 (Pubitemid 30067073)
12. W.E. Stamm Estrogens and urinarytract infection J Infect Dis 195 2007 623 624
13. L.E. Nicolle, and A.R. Ronald Recurrent urinary tract infection in adult women: diagnosis and treatment Infect Dis Clin North Am 1 1987 793 806
14. W.E. Stamm, and T.M. Hooton Management of urinary tract infections in adults N Engl J Med 329 1993 1328 1334 (Pubitemid 23317334)
15. A.R. Ronald, and B. Conway An approach to urinary tract infections in ambulatory women Curr Clin Top Infect Dis 9 1988 76 125
16. P. Abrams, S. Khoury, and A. Grant Evidence-based medicine overview of the main steps for developing and grading guideline recommendations Prog Urol 17 2007 681 684
17. U.S. Department of Health and Human Services Public Health Service Agency for Health Care Policy and Research; 1992. p. 115-27.
18. L.E. Nicolle Prophylaxis: recurrent urinary tract infection in women Infection 20 Suppl. 3 1992 S203 S205 [discussion p. S206-10]
19. L.D. Chew, and S.D. Fihn Recurrent cystitis in nonpregnant women West J Med 170 1999 274 277
20. X. Albert, I. Huertas, I.I. Pereiró, J. Sanfélix, V. Gosalbes, and C. Perrota Antibiotics for preventing recurrent urinary tract infection in non-pregnant women Cochrane Database Syst Rev 2004 CD001209
21. N. Rudenko, and A. Dorofeyev Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study Arzneimittelforschung 55 2005 420 427 (Pubitemid 41021086)
22. J.K. Kraft, and T.A. Stamey The natural history of symptomatic recurrent bacteriuria in women Medicine (Baltimore) 56 1977 55 60 (Pubitemid 8029160)
23. W.E. Stamm, M. Mc Kevitt, P.L. Roberts, and N.J. White Natural history of recurrent urinary tract infections in women Rev Infect Dis 13 1991 77 84
24. G.K. Harding, A.R. Ronald, L.E. Nicolle, M.J. Thomson, and G.J. Gray Long-term antimicrobial prophylaxis for recurrent urinary tract infection in women Rev Infect Dis 4 1982 438 443
25. L.E. Nicolle, G.K. Harding, M. Thomson, J. Kennedy, B. Urias, and A.R. Ronald Efficacy of five years of continuous, low-dose trimethoprims- ulfamethoxazole prophylaxis for urinary tract infection J Infect Dis 157 1988 1239 1242
26. W. Brumfitt, and J.M. Hamilton-Miller Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years' experience J Antimicrob Chemother 42 1998 363 371 (Pubitemid 28442450)
27. A. Pfau, and T.G. Sacks Effective prophylaxis of recurrent urinary tract infections in premenopausal women by postcoital administration of cephalexin J Urol 142 1989 1276 1278 (Pubitemid 19277963)
28. A. Pfau, and T.G. Sacks Effective postcoital quinolone prophylaxis of recurrent urinary tract infections in women J Urol 152 1994 136 138 (Pubitemid 24175721)
29. A. Pfau, and T.G. Sacks Effective prophylaxis for recurrent urinary tract infections during pregnancy Clin Infect Dis 14 1992 810 814
30. L.E. Nicolle, G.K. Harding, M. Thompson, J. Kennedy, B. Urias, and A.R. Ronald Prospective, randomized, placebo-controlled trial of norfloxacin for the prophylaxis of recurrent urinary tract infection in women Antimicrob Agents Chemother 33 1989 1032 1035 (Pubitemid 19168660)
31. A. Stapleton, R.H. Latham, C. Johnson, and W.E. Stamm Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. A randomized, doubleblind, placebo-controlled trial JAMA 264 1990 703 706 (Pubitemid 20246860)
32. M.D. Melekos, H.W. Asbach, E. Gerharz, I.E. Zarakovitis, K. Weingaertner, and K.G. Naber Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women J Urol 157 1997 935 939 (Pubitemid 27066282)
33. E.S. Wong, M. McKevitt, K. Running, G.W. Counts, M. Turck, and W.E. Stamm Management of recurrent urinary tract infections with patient-administered single-dose therapy Ann Intern Med 102 1985 302 307 (Pubitemid 15101857)
34. A.J. Schaeffer, and B.A. Stuppy Efficacy and safety of self-start therapy in women with recurrent urinary tract infections J Urol 161 1999 207 211 (Pubitemid 29422321)
35. K. Gupta, T.M. Hooton, P.L. Roberts, and W.E. Stamm Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women Ann Intern Med 135 2001 9 16 (Pubitemid 32619278)
36. T. Mazzei, M.I. Cassetta, S. Fallani, S. Arrigucci, and A. Novelli Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections Int J Antimicrob Agents 28 Suppl. 1 2006 S35 S41
37. K. Gupta, D.F. Sahm, D. Mayfield, and W.E. Stamm Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis Clin Infect Dis 33 2001 89 94 (Pubitemid 32554508)
38. D.F. Sahm, C. Thornsberry, D.C. Mayfield, M.E. Jones, and J.A. Karlowsky Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000 Antimicrob Agents Chemother 45 2001 1402 1406 (Pubitemid 32374109)
39. G.C. Schito, K.G. Naber, H. Botto, J. Palou, T. Mazzei, and L. Gualco The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections Int J Antimicrob Agents 34 2009 407 413
40. G.G. Zhanel, T.L. Hisanaga, N.M. Laing, M.R. DeCorby, K.A. Nichol, and B. Weshnoweski Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American urinary tract infection collaborative alliance (NAUTICA) Int J Antimicrob Agents 27 2006 468 475
41. G. Kahlmeter Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO. SENS study Int J Antimicrob Agents 22 Suppl. 2 2003 49 52
42. G. Fadda, G. Nicolletti, G.C. Schito, and G. Tempera Antimicrobial susceptibility patterns of contemporary pathogens from uncomplicated urinary tract infections isolated in a multicenter Italian survey: possible impact on guidelines J Chemother 17 2005 251 257 (Pubitemid 40992261)
43. R.C. Owens Jr., and P.G. Ambrose Torsades de pointes associated with fluoroquinolones. Pharmacotherapy 22 2002 663 668 [discussion p. 668-72]
44. J. Sode, N. Obel, J. Hallas, and A. Lassen Use of fluroquinolone and risk of Achilles tendon rupture: a population-based cohort study Eur J Clin Pharmacol 63 2007 499 503 (Pubitemid 46569916)
45. P.D. van der Linden, M.C. Sturkenboom, R.M. Herings, H.G. Leufkens, and B.H. Stricker Fluoroquinolones and risk of Achilles tendon disorders: case-control study BMJ 324 2002 1306 1307 (Pubitemid 34606771)
46. G. Corrao, A. Zambon, L. Bert, A. Mauri, V. Paleari, and C. Rossi Evidence of tendinitis provoked by fluoroquinolone treatment: a case-control study Drug Saf 29 2006 889 896 (Pubitemid 44511589)
47. H. Giamarellou, E. Kolokythas, G. Petrikkos, J. Gazis, D. Aravantinos, and P. Sfikakis Pharmacokinetics of three newer quinolones in pregnant and lactating women Am J Med 87 1989 49S 51S (Pubitemid 20005144)
48. Food and Drug Administration (FDA). CIPRO (ciprofloxacin) use by pregnant and lactating Women [available from: www.fda.gov/cder/drug/infopage/cipro/ ciprogreg.htm ].
49. W. Brumfitt, and J.M. Hamilton-Miller A comparative trial of low dose cefaclor and macrocrystalline nitrofurantoin in the prevention of recurrent urinary tract infection Infection 23 1995 98 102
50. P.E. Gower The use of small doses of cephalexin (125 mg) in the management of recurrent urinary tract infection in women J Antimicrob Chemother 1 Suppl. 3 1975 93 98
51. M. Falagas, K.P. Giannopoulou, G.N. Kokolakis, and P.I. Rafailidis Fosfomycin: use beyond urinary tract and gastrointestinal infections Clin Infect Dis 46 2008 1069 1077 (Pubitemid 351589875)
52. S.S. Patel, J.A. Balfour, and H.M. Bryson Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections Drugs 53 1997 637 656 (Pubitemid 27145957)
53. K. Hayashi Other antibiotics Clin Orthop Relat Res 1984 109 113 (Pubitemid 15223470)
54. P. Arca, G. Reguera, and C. Hardisson Plasmid-encoded fosfomycin resistance in bacteria isolated from the urinary tract in a multicentre survey J Antimicrob Chemother 40 1997 393 399 (Pubitemid 27437960)
55. J.I. Alos, P. Garcia-Pena, and J. Tamayo Biological cost associated with fosfomycin resistance in Escherichia coli isolates from urinary tract infections Rev Esp Quimioter 20 2007 211 215 (Pubitemid 47326190)
56. G. Kahlmeter, and P. Menday Crossresistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections J Antimicrob Chemother 52 2003 128 131 (Pubitemid 36850099)
57. The medical letter on drugs and therapeutics handbook of adverse drug interactions. New Rochelle, N.Y.: Medical Letter, Inc., 2000:196.
58. F. Barbut, and A. Richard Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea J Clin Microbiol 38 2000 2386 2388 (Pubitemid 30414372)
59. D.B. Blossom, and L.C. McDonald The challenges posed by reemerging Clostridium difficile infection Clin Infect Dis 45 2007 222 227 (Pubitemid 47041014)
60. T.M. Hooton Recurrent urinary tract infection in women Int J Antimicrob Agents 17 2001 259 268 (Pubitemid 32288741)